Effects of Feijining Decoction on vascular endothelial growth factor protein expression and changes of T cell subsets in Lewis lung carcinoma‑bearing mice

Zhou,Lijiang; Pan,Yuzhen; Xing,Yuqing; Gao,Hong; Xie,Xiaodong; Yin,Dongfeng

doi:10.3892/br.2015.432

Effects of Feijining Decoction on vascular endothelial growth factor protein expression and changes of T cell subsets in Lewis lung carcinoma‑bearing mice

Authors:
- Lijiang Zhou
- Yuzhen Pan
- Yuqing Xing
- Hong Gao
- Xiaodong Xie
- Dongfeng Yin
View Affiliations

Affiliations: Department of Oncology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110032, P.R. China, Department of Oncology, General Hospital of Shenyang Military Area Command, Shenyang, Liaoning 110840, P.R. China
Published online on: February 18, 2015 https://doi.org/10.3892/br.2015.432
Pages: 403-407

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Angiogenesis is crucial for cancer growth and metastasis. T cells are also key members of the adaptive immunity against tumorigenesis. The aim of the present study was to observe the effects of Feijining Decoction (FJND) on vascular endothelial growth factor (VEGF) protein expression and T cell subsets [cluster of differentiation 4+(CD4+) and CD8+ T lymphocyte] in Lewis lung carcinoma (LLC)‑bearing mice. C57BL/6J mice were subcutaneously implanted with LLC cells. Forty carcinoma‑bearing mice were randomly assigned to four groups (10 animals/group). The control group (CG) were the untreated group, the cisplatinum (DDP) group (DG) mice were treated with DDP, the FJND group (FG) were treated with FJND and the FJND + DDP group (FDG) were treated with FJND and DDP. Western blot and flow cytometry were used to evaluate the VEGF protein expression of tumor tissue and T cell subsets of the spleen. Spontaneous activity in 5 min was observed by the photoelectric counting method. DDP + FJND (FDG group) markedly inhibited tumor growth compared to the DG mice. The protein expression of VEGF was significantly downregulated in the carcinoma of FG mice compared to CG mice. VEGF protein expression was significantly reduced in FDG compared to DG mice. In the FG mice, the splenic CD4+ and CD4+/CD8+ cells were significantly increased compared to the CG mice, and the splenic CD4+ cells in the FDG mice were significantly increased compared to the DG group. In conclusion, FJND can inhibit tumor growth by downregulating VEGF protein expression and improving the immune function.

View Figures

View References

1	Ebos JM and Kerbel RS: Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol. 8:210–221. 2011. View Article : Google Scholar : PubMed/NCBI
2	Ramlau R, Gorbunova V, Ciuleanu TE, et al: Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial. J Clin Oncol. 30:3640–3647. 2012. View Article : Google Scholar : PubMed/NCBI
3	Cook KM and Figg WD: Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI
4	Zhang W and Yin DF: Effects of Feijining Decoction on apoptosis down-regulation of expression of VEGF in human lung adenocarcinoma cell line A549. Xian Dai Zhong Liu Xue Za Zhi. 21:330–332. 2007.[(In Chinese)].
5	Terme M1, Pernot S, Marcheteau E, et al: VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer. Cancer Res. 73:539–549. 2007. View Article : Google Scholar
6	Hamzah J, Jugold M, Kiessling F, et al: Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature. 453:410–414. 2008. View Article : Google Scholar : PubMed/NCBI
7	Barton DL, Soori GS, Bauer BA, et al: Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer. 18:179–187. 2010. View Article : Google Scholar : PubMed/NCBI
8	Suh SO, Kroh M, Kim NR, Joh YG and Cho MY: Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer. Am J Chin Med. 30:483–494. 2002. View Article : Google Scholar : PubMed/NCBI
9	Chen QJ, Zhang MZ and Wang LX: Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cell Physiol Biochem. 26:849–858. 2010. View Article : Google Scholar : PubMed/NCBI
10	Lü JM1, Yao Q and Chen C: Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 7:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
11	Zhang Y and Li PP: Evaluation of estrogenic potential of Shu-Gan-Liang-Xue Decoction by dual-luciferase reporter based bioluminescent measurements in vitro. J Ethnopharmacol. 126:345–349. 2009. View Article : Google Scholar : PubMed/NCBI
12	Zhang Y1 and Li PP: Shu-Gan-Liang-Xue Decoction, a Chinese herbal formula, down-regulates the expression of steroid sulfatase genes in human breast carcinoma MCF-7 cells. J Ethnopharmacol. 127:620–624. 2010. View Article : Google Scholar : PubMed/NCBI
13	Zhang W and Yin DF: Effects of Feijining Decoction on apoptosis down-regulation of expression of VEGF in human lung adenocarcinoma cell line A549. Xian Dai Zhong Liu Xue Za Zhi. 21:330–332. 2007.[(In Chinese)].
14	Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
15	Zhao J, Jiang P and Zhang W: Molecular networks for the study of TCM pharmacology. Brief Bioinform. 11:417–430. 2010. View Article : Google Scholar : PubMed/NCBI
16	Cao Z, Lin W, Huang Z, Chen X, Zhao J, Zheng L, Ye H, Liu Z, Liao L and Du J: Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro. Oncol Rep. 29:1080–1086. 2013.PubMed/NCBI
17	Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H and Zhang R: In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panaxginseng. Cancer Chemother Pharmacol. 59:589–601. 2007. View Article : Google Scholar : PubMed/NCBI
18	Kanayama H, Adachi N and Togami M: A new antitumor polysaccharide from the mycelia of Poria cocos wolf. Chem Pharm Bull (Tokyo). 31:1115–1118. 1983. View Article : Google Scholar : PubMed/NCBI
19	Peng Y, Sun M, Di Y, et al: Anti-tumor effect of the ethanol extract of Scutellaria baicalensis on the mice bearing U14 cervical cancer. Afr J Biotechnol. 11:6542–6549. 2012.
20	Lin J, Wei L, Xu W, Hong Z, Liu X and Peng J: Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis. Mol Med Rep. 4:1283–1288. 2011.PubMed/NCBI
21	Lin J, Chen Y, Wei L, Chen X, Xu W, Hong Z, Sferra TJ and Peng J: Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells. Int J Oncol. 37:1331–1338. 2010.PubMed/NCBI
22	Chen XZ, Cao ZY, Chen TS, Zhang YQ, Liu ZZ, Su YT, Liao LM and Du J: Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Oncol Rep. 28:742–748. 2012.PubMed/NCBI
23	Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T and Wang YT: Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo. J Ethnopharmacol. 141:721–727. 2012. View Article : Google Scholar : PubMed/NCBI
24	Chen W, Lu Y, Wu J, Gao M, Wang A and Xu B: Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemother Pharmacol. 67:799–808. 2011. View Article : Google Scholar : PubMed/NCBI
25	Mehnert A and Koch U: Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: A prospective study. Psychooncology. 16:181–188. 2007. View Article : Google Scholar : PubMed/NCBI
26	Maneeton B, Maneeton N, Reungyos J, Intaprasert S, Leelarphat S and Thongprasert S: Prevalence and relationship between major depressive disorder and lung cancer: A cross-sectional study. Onco Targets Ther. 7:815–821. 2014. View Article : Google Scholar : PubMed/NCBI
27	Arrieta O, Angulo LP, Nunez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Martinez-Lopez D, Alvarado S, Corona-Cruz JF and Onate-Ocaña LF: Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 20:1941–1948. 2013. View Article : Google Scholar : PubMed/NCBI
28	Piet J, Würtzen H and Zachariae R: The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: A systematic review and meta-analysis. J Consult Clin Psychol. 80:1007–1020. 2012. View Article : Google Scholar : PubMed/NCBI
29	Honggang Z, Bingkui P, Yongming Z, et al: Effect of Fei Liu Ping Ointment and its modified formula on dendritic cell. Beijing Zhong Yi Yao Da Xue Xue Bao. 30:525–527. 2007.[(In Chinese)].